Skip to main content
Exosens logo

Exosens — Investor Relations & Filings

Ticker · EXENS ISIN · FR001400Q9V2 LEI · 969500R3AKTPEDO9EG76 PA Manufacturing
Open in API
Filings indexed 99 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country FR France
Listing PA EXENS

About Exosens

http://www.exosens.com

Exosens is a high-tech company specializing in the innovation, development, and manufacture of high-end electro-optical technologies for amplification, detection, and imaging. The company provides mission-critical components and solutions for demanding environments. Its product portfolio covers a wide optical spectrum from ultraviolet (UV) to longwave infrared (LWIR) and includes image intensifier tubes, advanced digital and infrared cameras, and hyperspectral imaging systems. Exosens also produces a comprehensive range of detectors for electrons, ions, photons, X-rays, neutrons, and gamma radiation, as well as nuclear instrumentation and microwave amplifiers. These technologies serve key markets such as defense and surveillance, life sciences, industrial control, and nuclear safety.

Recent filings

Filing Released Lang Actions
Exosens unifie l’ensemble de ses produits sous une marque unique
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing the unification of product brands under the Exosens name. It contains no financial statements, shareholder vote results, management changes, dividend details, or other defined report content. It is not a financial report or meeting material but a general corporate announcement. Therefore, it falls into the catch-all Regulatory Filings category (RNS).
2026-05-13 French
Exosens unifies all its products under one brand
Regulatory Filings Classification · 24% confidence The document is a corporate press release announcing the unification of product brands under one name. It is not a financial report, earnings release, management or board change, proxy statement, dividend notice, or other specific filing type. It does not present actual financials, legal proceedings, or regulatory attestations, nor does it announce publication of a report. As such, it falls into the fallback category for miscellaneous corporate announcements: Regulatory Filings (RNS).
2026-05-13 English
Franchissement de seuils
Major Shareholding Notification Classification · 93% confidence The document is a formal declaration filed with the French Autorité des Marchés Financiers under article L. 233-7 of the French Commercial Code, notifying a corrected threshold‐crossing by DNCA Finance in the share capital of EXOSENS. It details share ownership levels and percentages, fitting the definition of a Major Shareholding Notification.
2026-05-11 French
Franchissement de seuils
Major Shareholding Notification Classification · 93% confidence The document is an AMF (Autorité des Marchés Financiers) “Déclaration de franchissement de seuils” under French commercial code L.233-7, reporting that DNCA Finance has crossed the 5% shareholding threshold in Exosens. This is precisely a notification of a change in significant share ownership levels (“major shareholding notification”).
2026-05-11 French
Exosens announces the availability of documents and information relating to the Combined General Meeting of 22 May 2026
AGM Information
2026-04-30 English
Exosens annonce la mise à disposition des documents et renseignements relatifs à l’Assemblée générale mixte du 22 mai 2026
AGM Information
2026-04-30 French

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.